Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Holding(s) in Company

17 Feb 2011 17:06

RNS Number : 4488B
Aortech International PLC
17 February 2011
ย 

๏ปฟ

TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

ย 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

AorTech International Plc

ย 

2. Reason for the notification (please state Yes/No):

An acquisition or disposal of voting rights: ( )

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( )

An event changing the breakdown of voting rights: ( )

Other (please specify): (Yes )

ย 

Loss of voting rights for Bluehone AiM VCT2 plc

ย 

3. Full name of person(s) subject to the notification obligation:

Bluehone Investors LLP

4. Full name of shareholder(s) (if different from 3.):

ย 

See box 9 below

ย 

5. Date of the transaction (and date on which the threshold is crossed or reached if different):

11 February 2011

6. Date on which issuer notified:

ย 

16 February 2011

ย 

7. Threshold(s) that is/are crossed or reached:

ย 

19%

ย 

8. Notified details:

ย 

ย 

A: Voting rights attached to shares:

ย 

Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction

Number of shares

Number of voting Rights

GB0033360586

962,841

962,841

ย 

Resulting situation after the triggering transaction

ย 

Class/type of shares if possible using the ISIN CODE

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0033360586

891,861

-

891,861

-

18.45%

ย 

B: Qualifying Financial Instruments

ย 

Resulting situation after the triggering transaction

Type of financial instrument

Expiration Date

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

ย 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

ย 

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/Conversion Period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

N/A

N/A

N/A

N/A

N/A

N/A

N/A

ย 

Total (A+B+C)

Number of voting rights

% of voting rights

891,861

ย 

18.45%

ย 

ย 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):

Bluehone Investors LLP

Client

No. of voting rights

% of total voting rights

Registration name

Active Capital Trust plc

891,861

18.45%

Chase Nominees Limited

ย 

ย 

ย 

Proxy Voting:

ย 

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

ย 

N/A

ย 

12. Date on which proxy holder will cease to hold voting rights:

ย 

N/A

ย 

13. Additional information:

ย 

Calculation based on TVR of 4,832,778. Bluehone AiM VCT2 plc continues to hold 70,980 shares, 1.48%. Transfer of investment manager from Bluehone Investors LLP to Maven Capital Partners UK LLP

14. Contact name:

ย 

Mike Bassi, F&C Asset Management plc, as Administrator of Bluehone Investors LLP

ย 

15. Contact number:

ย 

0131 718 1093

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
HOLGGUAUPUPGGMM
Date   Source Headline
17th Jun 20207:00 amRNSChange of Name and Rebranding
8th Jun 20207:00 amRNSUpdate on Elective Surgery and Customer Orders
27th May 20207:00 amRNSNew Patent
20th May 20207:00 amRNSGrant Funding for Subsidiary
13th May 20207:00 amRNSTrading Update
14th Apr 202010:27 amRNSFurther Update re COVID-19
2nd Apr 20202:13 pmRNSHolding(s) in Company
1st Apr 20201:36 pmRNSDirector/PDMR Shareholding
31st Mar 202010:28 amRNSResult of General Meeting and Total Voting Rights
30th Mar 20203:37 pmRNSUpdate re Acquisition of RUA and COVID-19
25th Mar 20207:00 amRNSUpdate re Acquisition and General Meeting
11th Mar 20207:00 amRNSProposed Acquisition of RUA Medical & Name Change
21st Jan 20207:00 amRNSExtension to Agreement with RUA Medical
6th Jan 20207:00 amRNSHeart Valve Development Update
2nd Dec 20197:00 amRNSNew Share Option Scheme and Grant of Share Options
29th Nov 20197:00 amRNSHalf-year Report
27th Nov 20191:09 pmRNSNew Licence Agreement
11th Oct 20197:00 amRNSTrading Update
3rd Sep 20191:14 pmRNSHolding(s) in Company
19th Aug 20192:53 pmRNSResult of AGM
5th Aug 20191:36 pmRNSPosting of Report & Accounts and Notice of Meeting
29th Jul 201912:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSFinal Results
8th Jul 201911:05 amRNSSecond Price Monitoring Extn
8th Jul 201911:00 amRNSPrice Monitoring Extension
19th Jun 20197:01 amRNSChange of Adviser
19th Jun 20197:00 amRNSDirectors' Disclosures
17th Jun 201910:47 amRNSDirectors' Disclosures
14th May 20197:00 amRNSTrading Update
24th Jan 201912:36 pmRNSCompany Update
22nd Nov 20187:00 amRNSInterim Results
15th Oct 20185:34 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 201811:18 amRNSHolding(s) in Company
23rd Aug 20182:03 pmRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement
26th Jul 20183:33 pmRNSHolding(s) in Company
25th Jul 20184:40 pmRNSSecond Price Monitoring Extn
25th Jul 20184:35 pmRNSPrice Monitoring Extension
20th Jul 20187:00 amRNSFinal Results
4th Jul 20187:00 amRNSNew Patent Issued
28th Jun 20187:00 amRNSDevelopment and Supply Agreement with RUA Medical
26th Jun 201812:49 pmRNSNew Patent Issued
19th Jun 20189:30 amRNSDevelopment Agreement Signed
15th Jun 20183:54 pmRNSHolding(s) in Company
13th Jun 201811:47 amRNSHolding(s) in Company
8th Jun 201812:02 pmRNSResult of GM and TVR
8th Jun 20187:00 amRNSResult of Open Offer
22nd May 201812:00 pmRNSPosting of Circular
21st May 20187:00 amRNSConditional Placing and Proposed Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.